A goal of the ongoing cancer-based research in the Pietenpol Laboratory is to provide new therapeutic approaches that specifically target the molecular interactions and biochemical pathways that are changed in tumor cells. The Laboratory was one of the first to pioneer chromatin immunoprecipatation techniques allowing analysis of p53 and identification of target genes involved in tumor suppression.
Professor of Biochemistry, Executive Vice President for Research, Director, Vanderbilt-Ingram Cancer Center, B.F. Byrd Jr. Professor of Oncology
698 Preston Research Building2220 Pierce AvenueNasville, TN 37232-6838